M. Bergamini

发表

TFOS DEWS II Clinical Trial Design Report.

P. Asbell, G. Novack, S. Schrader, 2017, The ocular surface.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

P. Netland, E. Sullivan, S. Robertson, 2001, American journal of ophthalmology.

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension

P. Netland, E. Sullivan, S. Robertson, 2003, Advances in therapy.

Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma

E. Bastia, A. Kothe, F. Impagnatiello, 2019, British journal of pharmacology.

The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.

E. Sullivan, C. F. Bosworth, J. Whitson, 2006, Ophthalmology.

A Three-Month, Multicenter, Double-Masked Study of the Safety and Efficacy of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Compared to Travoprost 0.004% Ophthalmic Solution and Timolol 0.5% Dosed Concomitantly in Subjects With Open Angle Glaucoma or Ocular Hypertension

B. Hughes, M. Bergamini, T. Landry, 2005, Journal of glaucoma.

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study.

R. D. Gross, M. Abelson, S. Robertson, 2004, Clinical therapeutics.

Topical flurbiprofen or prednisolone. Effect on corneal wound healing in rabbits.

D. Miller, M. Bergamini, P. Gruenberg, 1981, Archives of ophthalmology.

Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation.

A. Robin, A. Clark, T. Realini, 2009, American journal of ophthalmology.

The ocular hypotensive action of SK&F 86466 in the conscious rabbit.

J. Hieble, A. Sulpizio, W. D. Matthews, 1984, Current eye research.

Use of flurbiprofen to inhibit corneal neovascularization.

I. Leopold, M. Bergamini, C. A. Cooper, 1980, Archives of ophthalmology.

Disinfecting activities of non-peroxide soft contact lens cold disinfection solutions.

M. Bergamini, L. Caldwell, K. Shih, 1991, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: A population based study*

T. Einarson, A. Robin, O. Desjardins, 2009, Current medical research and opinion.

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.

John Samples, J. Samples, S. Orengo-Nania, 2005, American journal of ophthalmology.

Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group.

M. Bergamini, R. Notivol, M. Martinez, 1994, American journal of ophthalmology.

Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.

L. Desantis, N. Sharif, E. Sullivan, 2002, Survey of ophthalmology.

Effects of Travoprost on Aqueous Humor Dynamics in Patients With Elevated Intraocular Pressure

C. Camras, C. Toris, S. Fan, 2007, Journal of glaucoma.

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

J. Schuman, R. Lewis, E. Sullivan, 2005, American journal of ophthalmology.

Facility Changes Mediated by cAMP in the Bovine Anterior Segment In Vitro

R. Gilabert, C. Belmonte, X. Gasull, 1997, Vision Research.

Associations of Cytokine Concentrations With Key Osteopathic Lesions and Clinical Outcomes in Patients With Nonspecific Chronic Low Back Pain: Results From the OSTEOPATHIC Trial

J. Licciardone, Cathleen M. Kearns, M. Bergamini, 2012, The Journal of the American Osteopathic Association.

The Drug Discovery Process: How Do New Glaucoma Medications Come to Market?

M. Bergamini, 2010 .

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

S. Robertson, A. Weiner, H. Dubiner, 2004, Clinical therapeutics.

Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.

M. Bergamini, J. Dickerson, T. Landry, 2008, Ophthalmology.

Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%

E. Sullivan, R. Gross, M. Bergamini, 2007, Clinical ophthalmology.

NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs

E. Masini, A. Unser, E. Bastia, 2021, Investigative ophthalmology & visual science.

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension

D. Rhee, J. Peace, M. Bergamini, 2008, Clinical ophthalmology.

Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial.

R. D. Gross, A. Robin, L. Vijaya, 2008, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

Effects of time of storage, albumin, and osmolality changes on outflow facility (C) of bovine anterior segment in vitro.

R. Gilabert, C. Belmonte, A. Llobet, 1997, Investigative ophthalmology & visual science.

D. Rhee, J. Peace, M. Bergamini, 1820, Mims' Pathogenesis of Infectious Disease.

Comparison of the Safety and IOP–Lowering Efficacy of Travoprost 0.004%/Timolol 0.5% Fixed Combination to the Concomitant Administration of Xalatan® and Timolol 0.5%

D. S. Krueger, M. Bergamini, T. Landry, 2006 .